| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |